Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

OBJECTIVE: This study sought to examine the effect of ziprasidone on olanzapine or clozapine associated medical morbidity such as insulin resistance, diabetes mellitus and impaired fasting glucose, obesity and hyperlipidemia in patients with schizophrenia or schizoaffective disorder. METHOD: This wa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Psychopharmacol
Asıl Yazarlar: Henderson, David C., Fan, Xiaoduo, Copeland, Paul M., Sharma, Bikash, Borba, Christina P., Forstbauer, Sharon I., Miley, Kate, Boxill, Ryan, Freudenreich, Oliver, Cather, Corey, Evins, A. Eden, Goff, Donald C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327763/
https://ncbi.nlm.nih.gov/pubmed/19283774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.1012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller